发明名称 Herbal composition for treating various disorders including psoriasis, a process for preparation thereof and method for treatment of such disorders
摘要 <p>The invention provides a novel herbal composition containing the extracts of the leaves and/or stem of <italic>Argemone mexicana </highlight>plant, optionally containing the extracts of the fruits of <italic>Cuminum cyminum</highlight>, which exhibits useful in vitro, in vivo and interesting immunological and pharmacological activities; a process for preparation thereof; and a method of treatment of psoriasis and related immunological and biological disorders by administration of the said novel herbal composition. The useful in vitro, in vivo and interesting immunological and pharmacological activities exhibited by the extracts and fractions of the leaves and/or stem of <italic>Argemone mexicana </highlight>plant include immunosuppression, lymphoproliferation inhibition, cytokine modulation such as IL-2 inhibition, IFNgamma inhibition, IL-10 induction, keratinocyte proliferation inhibition, keratolytic activity, endothelial cell proliferation inhibition, inhibition of cell adhesion molecule expression such as ICAM-1, MEST inhibition, and enzymes inhibition such as p60src Tyrosine kinase, which are known to be involved in anti-psoriatic activity. The novel herbal composition(s) is useful in the treatment of various disorders, such as psoriasis including plaque psoriasis, gutatte psoriasis, pustular psoriasis and psoriasis of the nails; dermatitis and scleroderma; eczema; inflammatory disorders and other autoimmune diseases like psoriatic arthritis, rheumatoid arthritis, Crohn's disease, multiple sclerosis, irritable bowel disease, ankylosing spondilitis, systemic lupus erythremetosus and Sjogren's syndrome; allergies like asthma and chronic obstructive pulmonary disease and is safe, well-tolerated, non-toxic, with minimal and reversible adverse reactions or side effects, and most importantly, with minimal relapse or recurrence of the disease following completion of a treatment regimen. The invention also describes the presence of phosphodiesterase (III, IV and V) inhibition and 5-Lipoxygenase inhibition in the aqueous, ethanolic or aqueous-ethanolic extracts of fruits of <italic>Cuminum cyminum </highlight>plant.</p>
申请公布号 AU2003222436(B2) 申请公布日期 2007.09.20
申请号 AU20030222436 申请日期 2003.01.10
申请人 LUPIN LIMITED 发明人 VANDITA SRIVASTAVA;SANGANABHATLA NARENDAR;LAVLEEN KUMAR GUPTA;SUDERSHAN K ARORA;DINESH BALAKRISHNA SARAF
分类号 A61K9/06;A61K;A61K9/08;A61K9/10;A61K9/20;A61K9/48;A61K36/00;A61K36/18;A61K36/23;A61K36/66;A61K47/02;A61K47/10;A61K47/12;A61K47/26;A61K47/32;A61K47/34;A61K47/36;A61K47/38;A61K47/40;A61K47/44;A61P1/04;A61P11/00;A61P11/06;A61P17/00;A61P17/06;A61P19/02;A61P29/00;A61P37/02;A61P37/08;A61P43/00 主分类号 A61K9/06
代理机构 代理人
主权项
地址